Transcatheter mitral and tricuspid technologies Critical care technologies* Surgical valve technologies *Edwards Lifesciences Critical Care is now part of BD (Becton, Dickinson and …

Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient.

Investor Relations Corporate Overview Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.

Our locations With more than 16,000 employees across the globe, we celebrate our inclusive culture and embrace the diverse perspectives and experiences of our Edwards team. No …

Edwards Lifesciences Critical Care product group is now part of BD (Becton, Dickinson and Company). Edwards is the manufacturer of the products. To find the latest information, please …

Edwards Lifesciences is committed to providing reasonable accommodations and adjustments to individuals with a disability or neurodivergence. If you need an accommodation or adjustment …

USA and Canada Main locations Global headquarters Edwards Lifesciences Corp One Edwards Way Irvine, CA 92614

CLASP IID is a clinical trial from Edwards Lifesciences, reinforcing TEER as safe and effective for the treatment of patients with degenerative mitral regurgitation.

For more information about glutaraldehyde exposure, refer to the Safety Data Sheet available from Edwards Lifesciences. Conduction disturbances may occur before, during, or following …

Building from Edwards’ foundation rooted in the company’s Credo, the patient-focused culture and the unique innovation strategy, Zovighian and the global Edwards employees are united and …